Evaluation of Extended Interval Dosing Aminoglycosides in the Morbidly Obese Population

Table 2

Patient-specific data based on achievement level.

	Age	Percent above IBW	CrCl (mL/min)
High level; 𝑁=4	61.5±12.3	210.4%±27.1	107.3±53.1
Appropriate level; 𝑁=22	50.5±12.4	213.7%±25.9	137.1±44.0
Low level; 𝑁=5	43.4±14.7	206.0%±20.7	131.2±31.2